Prosztatarák: vizsgálatok itt: Egyesült Államok
656 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleEvaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
- Where
- Portland
- Életkor
- 18 év and over
- People
- 80
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT05919329 - 3. fázisTaking peopleA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Aberdeen, Atlanta, Aurora, Austin, Bala-Cynwyd, Baltimore, Billings, Carmel, Charleston, Charlottesville, Cleveland, Dallas, Detroit, Elmhurst, Fairfax, Fort Myers, Gahanna, Germantown, Grand Rapids, Highlands Ranch, Houston, Irvine, Lakewood, Las Vegas, Lexington, Lone Tree, Los Angeles, Marshall, Miami Beach, Milwaukee, Mitchell, Naperville, New Brunswick, New Haven, Omaha, Orange, Palo Alto, Pembroke Pines, Peoria, Philadelphia, Pierre, Redlands, Richmond, Riverside, Roanoke, Sacramento, Saint Louis Park, Saint Paul, San Francisco, Sioux Falls, Spokane, Syracuse, Towson, Tucson, Vallejo, Vancouver, Washington D.C., Yankton, Zanesville
- Életkor
- 18 év and over
- People
- 1314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00 - 1. fázisTaking peopleSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Where
- Atlanta, Denver, Los Angeles, Milwaukee, Newport, New York, Rochester, San Antonio
- Életkor
- 18 év and over
- People
- 100
- Run by
- Nammi Therapeutics Inc
See details and how to joinNCT06582017 - 1. fázisTaking peopleA Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Where
- Columbus, Durham, Madison, Miami, Myrtle Beach, New Hyde Park, New York, Port Saint Lucie, Rochester, San Antonio, San Francisco
- Életkor
- 18 év and over
- People
- 144
- Run by
- K36 Therapeutics, Inc.
See details and how to joinNCT07103018 - 3. fázisTaking peopleA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Arlington, Baltimore, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Dayton, Decatur, Denver, Duarte, East Syracuse, Fullerton, Goodyear, Hartford, Houston, Lansing, Leesburg, Los Angeles, Louisville, Midlothian, Minneapolis, Myrtle Beach, Nashville, Newark, Newnan, New York, Norfolk, Oklahoma City, Orange, Pittsburgh, Salem, San Francisco, Santa Monica, Tacoma, Tampa, Tucson, Tyler, Westwood, Zion
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674 - 2. fázisNot yet taking people in Egyesült ÁllamokHRT-PC Trial: Hormone Recovery After Treatment for Prostate Cancer Trial. An Open-label Phase II Study of Clomiphene Citrate in Patients With Persistent Hypogonadism After ADT for Treatment of Localized Prostate Cancer
- Where
- Omaha
- Életkor
- 19 év and over
- People
- 83
- Run by
- University of Nebraska
See details and how to joinNCT07882862 - No phaseTaking peopleLight Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 224
- Run by
- City of Hope Medical Center
See details and how to joinNCT05519878 - 2. fázisTaking peopleAbi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
- Where
- Omaha
- Életkor
- 30 év and over
- People
- 140
- Run by
- University of Nebraska
See details and how to joinNCT07237269 - 3. fázisTaking peopleAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Albuquerque, Aurora, Cleveland, Dayton, Detroit, Dothan, Duarte, Grand Rapids, Houston, Irvine, Metairie, Miami, Myrtle Beach, Nashville, New Hyde Park, Newport Beach, New York, O'Fallon, Omaha, Phoenix, Pittsburgh, Portland, Salt Lake City, San Francisco, St Louis, Tacoma, Westbrook
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - 2. fázisTaking peopleMeasuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 64
- Run by
- University of Washington
See details and how to joinNCT07698535 - No phaseTaking peopleCollection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- Where
- Bethesda
- Életkor
- 3 év and over
- People
- 1100
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01441089 - No phaseTaking peopleProfiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 10 000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03354416 - No phaseTaking peopleMen at High Genetic Risk for Prostate Cancer
- Where
- Bethesda
- Életkor
- 30 év to 75 év
- People
- 500
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03805919 - No phaseTaking peopleMultiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 508
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04692675 - No phaseTaking peopleStudy to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 30
- Run by
- City of Hope Medical Center
See details and how to joinNCT04775355 - No phaseTaking peopleA Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 1100
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04923178 - 2. fázisTaking people18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 130
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05155046 - 2. fázisTaking peopleFocal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 42
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05616650 - 2. fázisTaking peopleEnzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 65
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06096870 - 1. fázisTaking peopleA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Where
- Boston, Chicago, Cleveland, Metairie, Miami, New York, Omaha, Palo Alto, Portland, Rochester, San Diego, Tampa
- Életkor
- 18 év and over
- People
- 136 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06879041 - 1. fázisTaking peopleA First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- Where
- Dallas, Hackensack, Houston, Nashville, New York, Seattle, St Louis
- Életkor
- 18 év and over
- People
- 110
- Run by
- Moonlight Bio, Inc
See details and how to joinNCT07488923 - 1. fázisTaking peopleA Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy
- Where
- Little Rock
- Életkor
- 18 év to 100 év
- People
- 34
- Run by
- University of Arkansas
See details and how to joinNCT06044025 - 1/2. fázisTaking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Életkor
- 18 év and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - 3. fázisTaking peopleStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Where
- Albuquerque, Athens, Baltimore, Boston, Charleston, Chattanooga, Chicago, Cincinnati, Cooperstown, Denver, Detroit, East Brunswick, Fort Myers, Gahanna, Homewood, Iowa City, Kansas City, Lakeway, Metairie, Miami, Milwaukee, Morgantown, Myrtle Beach, New York, Omaha, Orange, Orlando, Palo Alto, Rochester, San Antonio, Santa Barbara, Scarborough, Seattle, St Louis, Syracuse, Tacoma, The Bronx, The Woodlands, Tucson, Voorhees Township
- Életkor
- 18 év to 100 év
- People
- 940 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06855277 - No phaseTaking peopleLow-Count Quantitative SPECT for Men Treated With Radium-223
- Where
- St Louis
- Életkor
- 18 év and over
- People
- 38
- Run by
- Washington University School of Medicine
See details and how to joinNCT07221825